life after glp-1 Maintaining weight loss stopping medication and metabolic balance so energy feels steadier and fullness feels more natural throughout the day. Life after GLP-1 | Snippet

Quick Takeaways Retatrutide is a triple-receptor agonist (GLP-1, GIP, glucagon) delivering superior monotherapy weight loss at 2428.7% over 4868 weeks Cagrilintide targets amylin receptors for satiety and gastric emptying, achieving 10.8% weight loss in 26 weeks as a monotherapy Retatrutide provides broader metabolic benefits, including dramatic improvements in HbA1c, blood pressure, waist circumference, insulin sensitivity, and liver fat normalization No head-to-head trials exist yet, but the mechanistic and clinical data strongly favor Retatrutide for total body recomposition Retatrutide vs Cagrilintide: Side-by-Side Comparison What Makes Retatrutide Different Retatrutide isnt just another GLP-1 receptor agonist

Another key benefit is its role in supporting liver health

Gradual dose escalation is usually used to help the body adjust and reduce discomfort

Over the past few years, GLP-1s have been effective at helping people reduce body fat, especially people who have struggled with their weight their entire lives

Following the FDA raid on their warehouse, Amino Asylum ceased all operations